Aspen Pharmacare Sustainability Profile
Aspen Pharmacare, a leading global pharmaceutical company headquartered in South Africa (ZA), has established itself as a key player in the healthcare industry since its founding in 1850. With a strong presence in over 50 countries, Aspen operates primarily in the areas of generic and branded pharmaceuticals, as well as consumer healthcare products. The company is renowned for its diverse portfolio, which includes anaesthetics, thrombosis, and oncology medications, setting it apart through a commitment to quality and innovation. Aspen's strategic acquisitions and partnerships have bolstered its market position, making it one of the largest pharmaceutical manufacturers in Africa. Notable achievements include its rapid expansion into international markets and a focus on sustainable healthcare solutions, reinforcing its reputation as a trusted provider in the global pharmaceutical landscape.
DitchCarbon Score
How does Aspen Pharmacare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aspen Pharmacare's score of 56 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aspen Pharmacare's reported carbon emissions
In 2024, Aspen Pharmacare reported total carbon emissions of approximately 140,983,000 kg CO2e globally, comprising about 32,468,000 kg CO2e from Scope 1 and about 108,515,000 kg CO2e from Scope 2 emissions. In South Africa, the company recorded total emissions of about 98,550,000 kg CO2e, with Scope 1 emissions at approximately 6,429,000 kg CO2e and Scope 2 emissions at about 92,121,000 kg CO2e. Aspen Pharmacare has set ambitious climate commitments, aiming to reduce global carbon dioxide emissions by 45% by 2030 relative to 2010 levels, with a long-term goal of achieving net zero emissions around mid-century. This commitment is based on the best available scientific knowledge and considers equity and sustainable development. The company has previously achieved significant reductions, including a 44% decrease in Scope 2 emissions from 158,035 kg CO2e to 88,008 kg CO2e between 2012 and 2013, and a 64% reduction in Scope 1 emissions during the same period. Aspen's climate strategy is aligned with industry standards, focusing on both Scope 1 and Scope 2 emissions, while currently lacking comprehensive data on Scope 3 emissions. The company's initiatives reflect a commitment to sustainability and responsible corporate practices in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 13,149,000 | 00,000,000 | - | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 34,934,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is Aspen Pharmacare's Industry?
How Carbon Intensive is Aspen Pharmacare's Location?
Aspen Pharmacare's Scope 3 Categories Breakdown
Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Fuel and Energy Related Activities" being the largest emissions source at 74% of Scope 3 emissions.
Top Scope 3 Categories
Aspen Pharmacare's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aspen Pharmacare has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
